Kyntra Bio, Inc. logo

Kyntra Bio, Inc. (KYNB)

Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
7. 23
-0.16
-2.1651%
$
29.63M Market Cap
- P/E Ratio
- Div Yield
9,400 Volume
-2.67 Eps
$ 7.39
Previous Close
Investors:
Add Transaction
Day Range
7.16 7.39
Year Range
6.32 12.6
Want to track KYNB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kyntra Bio, Inc. (KYNB) Q1 2026 Earnings Call Transcript

Kyntra Bio, Inc. (KYNB) Q1 2026 Earnings Call Transcript

Kyntra Bio, Inc. (KYNB) Q1 2026 Earnings Call Transcript

Seekingalpha | 2 months ago
Kyntra Bio (KYNB) Reports Q1 Loss, Tops Revenue Estimates

Kyntra Bio (KYNB) Reports Q1 Loss, Tops Revenue Estimates

Kyntra Bio (KYNB) came out with a quarterly loss of $3.74 per share versus the Zacks Consensus Estimate of a loss of $3.36. This compares to a loss of $4 per share a year ago.

Zacks | 2 months ago
Kyntra Bio (KYNB) Upgraded to Buy: Here's What You Should Know

Kyntra Bio (KYNB) Upgraded to Buy: Here's What You Should Know

Kyntra Bio (KYNB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks | 3 months ago
Kyntra Bio (KYNB) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Kyntra Bio (KYNB) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Kyntra Bio (KYNB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 4 months ago